Middle East Coronary and Peripheral Stents Market Outlook (2022-2033)

The Middle East coronary and peripheral stents market size is expected to reach US$ 291.1 million by 2033 from US$ 200.6 million in 2024. The market is estimated to record a CAGR of 4.2% from 2025 to 2033.

Executive Summary and Middle East Coronary and Peripheral Stents Market Analysis:

The Middle East coronary and peripheral stents market is steadily expanding, shaped by rising cardiovascular disease prevalence, lifestyle changes, and growing investments in healthcare modernization. The region benefits from increasing awareness of minimally invasive procedures and the availability of advanced stent technologies, including drug‑eluting and nitinol peripheral stents. Turkiye dominates the market, leveraging its large population, strong hospital network, and expanding interventional cardiology expertise. Urbanization and government initiatives to strengthen healthcare systems are driving demand, while private hospitals accelerate adoption of advanced devices. However, challenges such as reliance on imported products, regulatory delays, and uneven access in smaller markets act as restraints. Despite these hurdles, the Middle East remains strategically important, with Turkiye setting the pace for innovation, clinical adoption, and regional procurement strategies. Its leadership ensures that the region continues to evolve as a significant contributor to global stent market growth, balancing modernization with accessibility.

Middle East Coronary and Peripheral Stents Market Segmentation Analysis

Key segments that contributed to the derivation of the coronary and peripheral stents market analysis are product type, material type, application and end user.

• By product type, the coronary and peripheral stents market is segmented into bare-metal stents, drug-eluting stents, bioresorbable vascular scaffolds, and others. The drug-eluting stents segment dominated the market in 2024. Superior efficacy in reducing restenosis, longer-term patient outcomes, and widespread physician preference drove adoption, making them the most trusted choice compared to bare-metal or bioresorbable alternatives.
• By material type, the coronary and peripheral stents market is segmented into metal, polymer, and hybrid. The metal segment dominated the market in 2024. High durability, proven biocompatibility, cost-effectiveness, and established clinical success ensured dominance, as polymer and hybrid options remain limited in availability, scalability, and long-term performance validation.
• By application, the coronary and peripheral stents market is segmented into coronary artery disease and peripheral artery disease. The coronary artery disease segment dominated the market in 2024. Higher global prevalence, significant clinical burden, and greater demand for interventional procedures positioned coronary stents as the leading application, overshadowing peripheral artery disease interventions in overall market share.
• By end user, the market is segmented into hospitals, ambulatory surgical centers, cardiac catheterization labs, and specialty clinics. The hospitals segment held the largest share of the market in 2024. Comprehensive infrastructure, advanced catheterization facilities, skilled specialists, and ability to handle complex cases ensured hospitals remained the primary setting for stent implantation, surpassing smaller clinics and ambulatory centers.   

Middle East Coronary and Peripheral Stents Market Outlook

The Middle East market is characterized by rising demand for coronary drug‑eluting stents and peripheral stents, with hospitals and specialty clinics driving procurement. Clinical practices are increasingly aligned with global interventional cardiology standards, supported by structured physician training and partnerships with multinational manufacturers. A key driver is government investment in healthcare modernization, particularly in Turkiye, where large-scale hospital projects and expansion of catheterization labs are prioritized. This investment ensures broader access to interventional procedures, increasing stent utilization across both urban and semi‑urban populations. As healthcare infrastructure expands, physician expertise grows, and procurement pathways favor technologically advanced devices, adoption accelerates. This driver not only boosts procedural volumes but also encourages competitive pricing and innovation, reinforcing the Middle East’s position as a steadily growing market for coronary and peripheral stents. The modernization push is reshaping patient care, making advanced cardiovascular interventions more accessible and reliable across the region.

Middle East Coronary and Peripheral Stents Market Country Insights

Based on country, the Middle East coronary and peripheral stents market is further segmented into the UAE, Saudi Arabia, Bahrain, Oman, Kuwait, Qatar, and Turkiye. Turkiye held the largest share in 2024.

Turkiye dominates the Middle East coronary and peripheral stents market, driven by its large patient population, advanced hospital infrastructure, and strong government commitment to healthcare modernization. The country’s healthcare reforms emphasize cardiovascular care, leading to significant investments in catheterization labs, physician training, and procurement of advanced stent technologies. Multinational leaders such as Abbott, Boston Scientific, and Medtronic maintain strong presence, complemented by domestic manufacturers that compete on affordability and accessibility. Drug‑eluting stents are widely adopted as the standard of care, while peripheral stent usage is expanding in response to rising cases of peripheral artery disease. Turkiye’s centralized procurement systems and structured reimbursement policies facilitate timely access to innovative devices, reinforcing its leadership position. With continuous infrastructure development, clinical expertise, and a growing emphasis on research, Turkiye sets the benchmark for coronary and peripheral stent utilization across the Middle East, shaping regional adoption trends and ensuring sustained market growth.

Middle East Coronary and Peripheral Stents Market Company Profiles

Medtronic, Boston Scientific Corporation, Abbott, B. Braun SE, TERUMO CORPORATION, Teleflex Incorporated, Lepu Medical Technology (Beijing) Co. Ltd., Cook Medical, Meril Life Sciences and Translumina are among the key players operating in the market. These players adopt strategies such as expansion, product innovation, and mergers and acquisitions to stay competitive in the market and offer innovative products to their consumers.

Middle East Coronary and Peripheral Stents Market Research Methodology:

The following methodology has been followed for the collection and analysis of data presented in this report:

• Secondary Research

The research process begins with comprehensive secondary research, utilizing both internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:

• Company websites, annual reports, financial statements, broker analyses, and investor presentations
• Industry trade journals and other relevant publications
• Government documents, statistical databases, and market reports
• News articles, press releases, and webcasts specific to companies operating in the market

Note: All financial data included in the Company Profiles section has been standardized to US$. For companies reporting in other currencies, figures have been converted to US$ using the relevant exchange rates for the corresponding year.

• Primary Research

Business Market Insights conducts a significant number of primary interviews each year with industry stakeholders and experts to validate and analyze the data and gain valuable insights. These research interviews are designed to:

• Refine findings from secondary research
• Enhance the expertise and market understanding of the analysis team
• Gain insights into market size, trends, growth patterns, competitive dynamics, and future prospects

Primary research is conducted via email interactions and telephone interviews with industry experts across various markets, categories, segments, and sub-segments in different regions. Participants typically include:

• Industry stakeholders: Vice Presidents, business development managers, market intelligence managers, and national sales managers
• External experts: Valuation specialists, research analysts, and key opinion leaders with industry-specific expertise

Middle East Coronary and Peripheral Stents Key Sources Referred:

• The World Bank
• World Health Organization (WHO)
• Center for Disease Control and Prevention (CDC)
• European Society of Cardiology
• American College of Cardiology
• American Heart Association
• Asian Pacific Society of Interventional Cardiology
• Company website
• Company annual reports
• Company investor presentations